Home

Search Abstracts

Browse Sessions

Program Committee

Conference Webcasts

Contact Us

---

Session 63   Poster Abstracts Host Genetic Factors Tuesday, 1:30 - 3:30 pm Poster Hall

401	Association of CCR5 Promoter Human Haplogroup E with Faster HIV-1 Disease Progression among Injection Drug Users in Thailand C Yang*1, L Nguyen1, T Chaowanachan2, S Vanichseni3, M Li1, P A Mock2, F Van Griensven1,2, M Martin2, U Sangkum4, K Choopanya3, J W Tappero1,2, R B Lal1, and D J Hu1 1CDC, Atlanta, GA, USA; 2Thai MOPH-US CDC Collaboration, Nonthaburi, Thailand; 3Bangkok Vaccine Evaluation Group, Thailand; and 4Bangkok Metropolitan Admin., Bangkok, Thailand
402	Causal Mechanisms of the Effects of Age and the CCR-Delta32, CCR-64I, and SDF-1 3'A Alleles on AIDS Development R Geskus*1, L Meyer2, J-B Hubert2, H Schuitemaker3, B Berkhout4, C Rouzioux5, I Theodorou6, J-F Delfraissy2, M Prins1, and R Coutinho1 1Municipal Hlth. Svc., Amsterdam, The Netherlands; 2Hosp. de Bicêtre, Le Kremlin-Bicêtre, France; 3CLB Sanquin Div., Amsterdam, The Netherlands; 4Academic Med. Ctr., Amsterdam, The Netherlands; 5Hosp. Necker, Paris, France; and 6Hosp. Pitié Salpêtrière, Paris, France
403	HLA-DRB1, -DQB1, and HLA-B Associations with Early HIV-1 Viral Load in Seroconverters from the Multicenter AIDS Cohort Study R A Kaslow*1, J Tang1, X Gao2, G Cloud1, N Makhatadze1, R Detels3, S O’Brien2, and M Carrington2 1Univ. of Alabama at Birmingham, USA; 2NCI, NIH, DHHS, Frederick, MD, USA; and 3Univ. of California, Los Angeles, USA
404	HIV Infection and Disease Progression Are Not Accelerated by the MCP-1-2578G Mutant Allele in the ANRS SEROCO Cohort L Meyer*1, S Casanova2, A Persoz1, C Rouzioux2, I Theodorou2, J-F Delfraissy1, C Combadiere2, and SEROCO Study Group 1Le Kremlin Bicetre, France and 2Paris, France
405	The Effect of Escape Mutations upon Disease Progression in HLA B27 Positive Individuals within The Australian Long-term Non-progressor Cohort P Ammaranond*1, J Guerin1, B Anderson2, C Doong3, R Finlayson4, M Kelly5, M McMurchie6, R Price4, D Cooper1, A Kelleher1, and on behalf of the LTNP study group 1Natl. Ctr. in HIV Epidemiology and Clin. Res., Univ. of New South Wales, Sydney, Australia; 2St. Leonard's Med. Ctr., Sydney, Australia; 3Burwood Practice, Sydney, Australia; 4Taylor Square Private Clin., Sydney, Australia; 5Albion St. Clin., Sydney, Australia; and 6407 Doctors, Sydney, Australia
406	HLA Class 1 Genotype and HIV Genome Evolution During Primary Infection F Bernardin*1,2, L-A Baxter-Lowe2, L Peddada3, and E Delwart1,2 1Blood Systems Res. Inst., San Francisco, CA, USA; 2Univ. of California, San Francisco, USA; and 3Alpha Therapeutic Corp., Los Angeles, CA, USA
407	The Breadth and Magnitude of T-lymphocyte Responses to HIV-1 Antigens Are Associated with Cytokine Gene Polymorphisms W Song*, J Tang, P A Goepfert, C Wang, A Bansal, S Sabbaj, M J Mulligan, C M Wilson, and R A Kaslow Univ. of Alabama at Birmingham, USA
408	Fas and Fas Ligand Polymorphisms Influence the Rise in CD4+ T-cell Count after Antiretroviral Therapy in Drug-naïve HIV+ Patients M Nasi, M Pinti, R Bugarini, L Troiano, E Lugli, C Bellodi, C Mussini, V Borghi, R Esposito, and A Cossarizza* Univ. of Modena and Reggio Emilia and Azienda Policlin., Italy